The Impact of Sequence of Chemotherapy and EGFR-TKI Treatment on Different EGFR Mutation Lung Adenocarcinoma

Objectives. Chemotherapy as first-/second-line treatment in different epidermal growth factor receptor (EGFR) mutation lung adenocarcinoma remains controversial. Methods. Consecutive patients were collected between 2009 and 2012. Patients were divided into two groups (1st-line chemotherapy: n = 56 a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Biomed Res Int
Autors principals: Chung, Fu-Tsai, Ho, Ming-Yun, Fang, Yueh-Fu, Hshieh, Meng-Heng, Wang, Tsai-Yu, Kuo, Chih-Hsi, Chen, Hao-Cheng, Wang, Chun-Hwa, Lin, Shu-Min, Yu, Chih-Teng, Lin, Horng-Chyuan, Kuo, Han-Pin
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2015
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4644829/
https://ncbi.nlm.nih.gov/pubmed/26609535
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/948267
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars